Abstract
The COVID-19 pandemic raises the need for diverse diagnostic approaches to rapidly detect different stages of viral infection. The flexible and quantitative nature of single-molecule imaging technology renders it optimal for development of new diagnostic tools. Here we present a proof-of-concept for a single-molecule based, enzyme-free assay for detection of SARS-CoV-2. The unified platform we developed allows direct detection of the viral genetic material from patients' samples, as well as their immune response consisting of IgG and IgM antibodies. Thus, it establishes a platform for diagnostics of COVID-19, which could also be adjusted to diagnose additional pathogens.
| Original language | English |
|---|---|
| Article number | e0255096 |
| Journal | PLoS ONE |
| Volume | 16 |
| Issue number | 7 July |
| DOIs | |
| State | Published - Jul 2021 |
Bibliographical note
Publisher Copyright:© 2021 Public Library of Science. All rights reserved.
Funding
| Funders | Funder number |
|---|---|
| National Institute of Allergy and Infectious Diseases | ZIAAI005066 |
Fingerprint
Dive into the research topics of 'Unified platform for genetic and serological detection of COVID-19 with single-molecule technology'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver